Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789658 | 12378965 | 8 | F | 20160801 | 20160517 | 20160912 | EXP | US-GILEAD-2015-0175816 | GILEAD | 66.00 | YR | E | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789658 | 12378965 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, UNK | Y | 22081 | 10 | MG | TABLET | ||||||
| 123789658 | 12378965 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/MIN CONTINUOUSLY17 NG/KG/MIN CONTINUOUSLY, CONCENTRATION: 45,000 NG/ML, 50 ML PER DAY [...] | U | N437 | 0 | ||||||||
| 123789658 | 12378965 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/M CONTINUOUSLY, CONCENTRATION: 45,000 NG/ML, VIAL STRENGTH: 1.5 MG, PUMP RATE: 50 ML/DAY | U | U202 | 0 | ||||||||
| 123789658 | 12378965 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 50 ML/DAY, VIAL STRENGTH 1.5 MG/ML) CO | U | Z880 | 0 | ||||||||
| 123789658 | 12378965 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 17 NG/KG/MIN CONTINUOUSLY | U | N848 | 0 | ||||||||
| 123789658 | 12378965 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 17 NG/KG/MIN CONTINUOUSLY | U | P828 | 0 | ||||||||
| 123789658 | 12378965 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 17 NG/KG/MIN CONTINUOUSLY | U | R271A | 0 | ||||||||
| 123789658 | 12378965 | 8 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 17 NG/KG/MIN CONTINUOUSLY | U | S706 | 0 | ||||||||
| 123789658 | 12378965 | 9 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/M CONTINUOUSLY, CONCENTRATION: 45,000 NG/ML, VIAL STRENGTH: 1.5 MG, PUMP RATE: 50 ML/DAY | U | S925 | 0 | ||||||||
| 123789658 | 12378965 | 10 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/MG CO CONCENTRATION: 45,000 NG/ML, VIAL STRENGTH: 1.5 MG, PUMP RATE: 50 ML/DAY | U | T366 | 0 | ||||||||
| 123789658 | 12378965 | 11 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 50 ML/DAY, VIAL STRENGTH 1.5 MG), CO | U | U052 | 0 | ||||||||
| 123789658 | 12378965 | 12 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 50 ML/DAY, VIAL STRENGTH 1.5 MG/ML) CO | U | Z111 | 0 | ||||||||
| 123789658 | 12378965 | 13 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 123789658 | 12378965 | 14 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 17 NG/KG/MIN CONTINUOUSLY | U | N848 | 0 | |||||||||
| 123789658 | 12378965 | 15 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 17 NG/KG/MIN CONTINUOUSLY | U | P828 | 0 | |||||||||
| 123789658 | 12378965 | 16 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 17 NG/KG/MIN CONTINUOUSLY | U | R271A | 0 | |||||||||
| 123789658 | 12378965 | 17 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 17 NG/KG/MIN CONTINUOUSLY | U | S706 | 0 | |||||||||
| 123789658 | 12378965 | 18 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/M CONTINUOUSLY, CONCENTRATION: 45,000 NG/ML, VIAL STRENGTH: 1.5 MG, PUMP RATE: 50 ML/DAY | U | S925 | 0 | ||||||||
| 123789658 | 12378965 | 19 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/MG CO CONCENTRATION: 45,000 NG/ML, VIAL STRENGTH: 1.5 MG, PUMP RATE: 50 ML/DAY | U | T366 | 0 | ||||||||
| 123789658 | 12378965 | 20 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17 NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 50 ML/DAY, VIAL STRENGTH 1.5 MG), CO | U | U052 | 0 | ||||||||
| 123789658 | 12378965 | 21 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 17NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 50 ML/DAY, VIAL STRENGTH 1.5 MG/ML) CO | U | Z111 | 0 | ||||||||
| 123789658 | 12378965 | 22 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | U | UNKNOWN | 0 | ||||||||||
| 123789658 | 12378965 | 23 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK, U | U | 0 | |||||||||
| 123789658 | 12378965 | 24 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK, U | U | 0 | |||||||||
| 123789658 | 12378965 | 25 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK, U | U | 0 | |||||||||
| 123789658 | 12378965 | 26 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK, U | U | 0 | |||||||||
| 123789658 | 12378965 | 27 | SS | INTRAVENOUS IMMUNOGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | UNK, U | U | 0 | |||||||||
| 123789658 | 12378965 | 28 | SS | OXYCODONE | OXYCODONE | 1 | Unknown | U | 0 | ||||||||||
| 123789658 | 12378965 | 29 | SS | DANAZOL. | DANAZOL | 1 | Y | U | 0 | ||||||||||
| 123789658 | 12378965 | 30 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 0 | ||||||||||||
| 123789658 | 12378965 | 31 | C | HYDROCODONE | HYDROCODONE | 1 | 10 MG EVERY FOUR HOURS | U | 0 | 10 | MG | ||||||||
| 123789658 | 12378965 | 32 | C | HYDROCODONE | HYDROCODONE | 1 | 10 MG EVERY FOUR HOURS | U | 0 | 10 | MG | ||||||||
| 123789658 | 12378965 | 33 | C | HYDROCODONE | HYDROCODONE | 1 | 10 MG EVERY FOUR HOURS | U | 0 | 10 | MG | ||||||||
| 123789658 | 12378965 | 34 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123789658 | 12378965 | 1 | Product used for unknown indication |
| 123789658 | 12378965 | 2 | Pulmonary arterial hypertension |
| 123789658 | 12378965 | 22 | Pulmonary arterial hypertension |
| 123789658 | 12378965 | 23 | Product used for unknown indication |
| 123789658 | 12378965 | 27 | Product used for unknown indication |
| 123789658 | 12378965 | 28 | Product used for unknown indication |
| 123789658 | 12378965 | 29 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123789658 | 12378965 | OT |
| 123789658 | 12378965 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123789658 | 12378965 | Back pain | |
| 123789658 | 12378965 | Head discomfort | |
| 123789658 | 12378965 | Headache | |
| 123789658 | 12378965 | Hepatic cirrhosis | |
| 123789658 | 12378965 | Medication overuse headache | |
| 123789658 | 12378965 | Migraine | |
| 123789658 | 12378965 | Pain | |
| 123789658 | 12378965 | Pain in extremity | |
| 123789658 | 12378965 | Platelet count decreased | |
| 123789658 | 12378965 | Platelet disorder | |
| 123789658 | 12378965 | Rash | |
| 123789658 | 12378965 | Tooth infection | |
| 123789658 | 12378965 | Vibratory sense increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123789658 | 12378965 | 1 | 20150923 | 0 | ||
| 123789658 | 12378965 | 2 | 19991022 | 0 | ||
| 123789658 | 12378965 | 3 | 19991223 | 0 | ||
| 123789658 | 12378965 | 4 | 20070131 | 0 |